Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00451_DB01164_nanopub.RAtRLXlwKi-SrBuEmZBJaJyGYFgyVv3J3v4oLUzHkm0Ls#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00451_DB01164 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00451_DB01164 label "DDI between Levothyroxine and Calcium Chloride - Calcium salts such as calcium chloride may diminish the therapeutic effect of thyroid products such as levothyroxine. Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours. Monitor for decreased therapeutic effects of thyroid products if an oral calcium supplement is initiated/dose increased, or increased effects if an oral calcium supplement is discontinued/dose decreased. [drugbank_resource:DB00451_DB01164]" assertion.
- drugbank_resource:DB00451_DB01164 identifier "drugbank_resource:DB00451_DB01164" assertion.
- drugbank_resource:DB00451_DB01164 title "DDI between Levothyroxine and Calcium Chloride - Calcium salts such as calcium chloride may diminish the therapeutic effect of thyroid products such as levothyroxine. Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours. Monitor for decreased therapeutic effects of thyroid products if an oral calcium supplement is initiated/dose increased, or increased effects if an oral calcium supplement is discontinued/dose decreased." assertion.
- drugbank:DB01164 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00451_DB01164 assertion.
- drugbank:DB00451 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00451_DB01164 assertion.